The Role of Genetic Factors in the Development of Bronchial Asthma in the Kazakh Population
NCT ID: NCT05088512
Last Updated: 2023-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2021-10-23
2023-01-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genetic Risk Factors for Severe Asthma
NCT00090740
Novel Gentic Variations Contributing to Asthma Susceptability in Saudi Arabia
NCT01216215
Identification of an Asthma Susceptibility Gene on 3P
NCT00006510
Genetic Study of Familial Forms of Non-atopic Asthma
NCT02911220
Association Between Genetic Polymorphisms and Type 2 Asthma in Children
NCT06840717
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group:
Patients with bronchial asthma
SNP analysis of the DNA
SNP analysis of the DNA obtained from peripheral blood sample
Control group
Patients without bronchial asthma
SNP analysis of the DNA
SNP analysis of the DNA obtained from peripheral blood sample
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SNP analysis of the DNA
SNP analysis of the DNA obtained from peripheral blood sample
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The age of the patients is from 5 to 60 years;
* Persons of Kazakh nationality, whose paternal and maternal grandparents are Kazakhs.
* Persons who are able and willing to provide written informed consent;
* Persons capable and willing to comply with the research protocol;
Exclusion Criteria
* Pregnant or lactating women;
* Tuberculosis of any localization in the active phase and in history;
* Severe and decompensated diseases of the liver and kidneys, cardiovascular system;
* Severe and decompensated course of endocrine diseases;
* Autoimmune diseases;
* Systemic diseases;
* Oncological diseases;
5 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asfendiyarov Kazakh National Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ildar Fakhradiyev
Project manager
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kazakhstan
Almaty, , Kazakhstan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1207
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.